Which Interstitial Lung Disease (ILD) tends to respect the pleura?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Which Interstitial Lung Disease Respects the Pleura?

Most interstitial lung diseases actually spare the pleura rather than involve it, with the notable exception being Pleuroparenchymal Fibroelastosis (PPFE), which is unique in that it specifically involves both the pleura and subpleural lung parenchyma rather than respecting it. 1

Understanding Pleural Involvement vs. Pleural Sparing

The question of which ILD "respects" the pleura requires clarification of terminology:

  • Most ILDs spare (respect) the pleura: The typical ILDs like IPF/UIP, NSIP, and others generally do not involve the pleural surface itself, though they may have subpleural distribution of parenchymal disease 1

  • PPFE is the exception: This rare ILD is characterized by fibrosis that specifically involves the pleura and subpleural lung parenchyma, predominantly in the upper lobes 1

Key Distinguishing Features of PPFE

PPFE demonstrates dense subpleural consolidation with traction bronchiectasis, architectural distortion, and upper lobe volume loss on HRCT. 1, 2

Diagnostic HRCT Characteristics:

  • Irregular pleural-based opacities in the upper lobes with associated reticular patterns and parenchymal distortion 2
  • Dense subpleural consolidation with traction bronchiectasis 1, 2
  • Upper lobe predominance (though lower lobe involvement may occur) 2
  • The fibrosis is elastotic with intraalveolar fibrosis present histologically 1

Clinical Features to Recognize:

  • Pneumothorax is common and should raise suspicion for PPFE 1, 2
  • Approximately 50% of patients have experienced recurrent infections 1
  • Median age of presentation is 57 years with no sex predilection 1
  • Disease progression occurs in 60% of patients with death from disease in 40% 1

Clinical Context

PPFE can occur as an isolated entity or coexist with other ILDs, particularly IPF (seen in 6-10% of IPF cases). 2 When PPFE coexists with IPF, it is associated with more rapid decline in lung function, higher risk of pneumothorax and pneumomediastinum, and poorer survival 2

Important Caveat:

The subpleural and pleural-based distribution with elastotic fibrosis distinguishes PPFE from typical UIP patterns, which have subpleural predominance but do not involve the pleural surface itself 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

HRCT Criteria for Pleuroparenchymal Fibroelastosis (PPFE)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.